NCT05778851View on ClinicalTrials.gov

Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 19, 2024

Conditions
Barrett Esophagus
Interventions
DEVICE

EsoGuard result

Education slide-set EsoGuard and patient cases including EsoGuard result

Trial Locations (1)

10017

Lucid Diagnostics, New York

Sponsors

Collaborators (1)

Medex15
All Listed Sponsors
collaborator

Medex15

INDUSTRY

lead

Lucid Diagnostics, Inc.

INDUSTRY